Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors
This study evaluated the incidence, characteristics, and risk factors of RICE after PBT delivered to, or in direct proximity to, the brain and its effect on health-related quality of life (HRQoL). (Source: International Journal of Radiation Oncology * Biology * Physics)
Source: International Journal of Radiation Oncology * Biology * Physics - January 18, 2024 Category: Radiology Authors: Carola L ütgendorf-Caucig, Maciej Pelak, Eugen Hug, Birgit Flechl, Birgit Surböck, Christine Marosi, Ulrike Mock, Leor Zach, Yael Mardor, Orit Furman, Harald Hentschel, Joanna Gora, Piero Fossati, Markus Stock, Uwe Graichen, Sascha Klee, Petra Georg Tags: CLINICAL INVESTIGATION Source Type: research
Cancers, Vol. 16, Pages 403: Dosimetric Comparison Study of Proton Therapy Using Line Scanning Versus Passive Scattering and Volumetric Modulated Arc Therapy for Localized Prostate Cancer
Conclusion: The LS method demonstrated a reduction in rectal and bladder doses relative to PS and VMAT, thereby suggesting the potential for mitigating toxicities. (Source: Cancers)
Source: Cancers - January 17, 2024 Category: Cancer & Oncology Authors: Masaru Takagi Yasuhiro Hasegawa Kunihiko Tateoka Yu Takada Masato Hareyama Tags: Article Source Type: research
Cancers, Vol. 16, Pages 330: The Role of Proton Therapy for Prostate Cancer in the Setting of Hip Prosthesis
Conclusions: PT for treatment of prostate cancer patients with hip prosthesis is feasible and equivalent or potentially superior to VMAT in quality in some cases. The choice of radiotherapy regimen can be personalized based on patient characteristics to achieve the best treatment outcome. (Source: Cancers)
Source: Cancers - January 11, 2024 Category: Cancer & Oncology Authors: Maryam Moteabbed Mislav Bobi ć Harald Paganetti Jason A. Efstathiou Tags: Article Source Type: research
Cancers, Vol. 16, Pages 221: Feasibility of Synchrotron-Based Ultra-High Dose Rate (UHDR) Proton Irradiation with Pencil Beam Scanning for FLASH Research
Conclusions: The synchrotron-based proton therapy system has the capability to deliver pulsed proton UHDR PBS beams. The maximum deliverable dose and field size per pulse are limited by the spill length and extraction charge. (Source: Cancers)
Source: Cancers - January 3, 2024 Category: Cancer & Oncology Authors: Lingshu Yin Umezawa Masumi Kan Ota Daniel M. Sforza Devin Miles Mohammad Rezaee John W. Wong Xun Jia Heng Li Tags: Article Source Type: research
Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012-21) from the National Association for Proton Therapy
The XXXX conducted eight surveys of all operational United States proton centers (2012-2021), analyzing patients treated, diagnoses, treatment complexity, to evaluate trends and diversification of patients receiving proton therapy. (Source: International Journal of Radiation Oncology * Biology * Physics)
Source: International Journal of Radiation Oncology * Biology * Physics - December 30, 2023 Category: Radiology Authors: William F. Hartsell, Charles B. Simone, Deborah Godes, Jennifer Maggiore, Minesh P. Mehta, Steven J. Frank, James M. Metz, J. Isabelle Choi Tags: Clinical Investigation Source Type: research
Establishing a consumer advisory group at the Australian Bragg Centre for Proton Therapy and Research
J Med Radiat Sci. 2023 Dec 26. doi: 10.1002/jmrs.746. Online ahead of print.ABSTRACTThe Australian Bragg Centre for Proton Therapy and Research (ABCPTR) established the Bragg Consumer Advisory Group (BCAG) in 2023. The ABCPTR, being the first of its kind in Australia, will offer proton therapy treatment for challenging solid tumours with the potential to reduce radiation-induced side effects. With over 110 Proton Beam Therapy (PBT) centres globally, Australian patients currently can apply to access government funded treatment overseas, however, international travel for treatment presents various, significant challenges. Co...
Source: Cancer Control - December 26, 2023 Category: Cancer & Oncology Authors: Melanie Penfold Peter Gorayski Julia Green Kelly Skelton Source Type: research
Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and Research
This article provides an overview of the current landscape, highlighting the potential benefits and challenges of a treatment that could redefine the quality of survivorship and contribute to global research and best clinical practice. (Source: Journal of Medical Imaging and Radiation Oncology)
Source: Journal of Medical Imaging and Radiation Oncology - December 26, 2023 Category: Radiology Authors: Jeremy Khong,
Hui Tee,
Peter Gorayski,
Hien Le,
Michael Penniment,
Sophie Jessop,
Jordan Hansford,
Melanie Penfold,
Julia Green,
Kelly Skelton,
Frank Saran Tags: Radiation Oncology —Review Article Source Type: research
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations
CONCLUSIONS: Given the effectiveness of systemic treatments in hematologic malignancies, the oligometastasis stage is of little importance. A curative intent after local radiation therapy, even advanced stage, is possible, both with residual disease for advanced Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or solitary plasmocytoma, and even without evidence of disease after chemotherapy for Hodgkin or non-Hodgkin lymphoma. The role of new treatments, such as CAR T cells, allows us to consider radiation therapy after systemic treatment of relapsed diseases with low volume recurrence, which can be considered oligorecur...
Source: Cancer Radiotherapie - December 24, 2023 Category: Cancer & Oncology Authors: L Ollivier K Debbi N-H To A Cailleteau S Supiot A Mervoyer V Guimas Y Belkac émi Source Type: research
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations
CONCLUSIONS: Given the effectiveness of systemic treatments in hematologic malignancies, the oligometastasis stage is of little importance. A curative intent after local radiation therapy, even advanced stage, is possible, both with residual disease for advanced Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or solitary plasmocytoma, and even without evidence of disease after chemotherapy for Hodgkin or non-Hodgkin lymphoma. The role of new treatments, such as CAR T cells, allows us to consider radiation therapy after systemic treatment of relapsed diseases with low volume recurrence, which can be considered oligorecur...
Source: Cancer Radiotherapie - December 24, 2023 Category: Cancer & Oncology Authors: L Ollivier K Debbi N-H To A Cailleteau S Supiot A Mervoyer V Guimas Y Belkac émi Source Type: research
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations
CONCLUSIONS: Given the effectiveness of systemic treatments in hematologic malignancies, the oligometastasis stage is of little importance. A curative intent after local radiation therapy, even advanced stage, is possible, both with residual disease for advanced Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or solitary plasmocytoma, and even without evidence of disease after chemotherapy for Hodgkin or non-Hodgkin lymphoma. The role of new treatments, such as CAR T cells, allows us to consider radiation therapy after systemic treatment of relapsed diseases with low volume recurrence, which can be considered oligorecur...
Source: Cancer Radiotherapie - December 24, 2023 Category: Cancer & Oncology Authors: L Ollivier K Debbi N-H To A Cailleteau S Supiot A Mervoyer V Guimas Y Belkac émi Source Type: research
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations
CONCLUSIONS: Given the effectiveness of systemic treatments in hematologic malignancies, the oligometastasis stage is of little importance. A curative intent after local radiation therapy, even advanced stage, is possible, both with residual disease for advanced Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or solitary plasmocytoma, and even without evidence of disease after chemotherapy for Hodgkin or non-Hodgkin lymphoma. The role of new treatments, such as CAR T cells, allows us to consider radiation therapy after systemic treatment of relapsed diseases with low volume recurrence, which can be considered oligorecur...
Source: Cancer Radiotherapie - December 24, 2023 Category: Cancer & Oncology Authors: L Ollivier K Debbi N-H To A Cailleteau S Supiot A Mervoyer V Guimas Y Belkac émi Source Type: research
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations
CONCLUSIONS: Given the effectiveness of systemic treatments in hematologic malignancies, the oligometastasis stage is of little importance. A curative intent after local radiation therapy, even advanced stage, is possible, both with residual disease for advanced Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or solitary plasmocytoma, and even without evidence of disease after chemotherapy for Hodgkin or non-Hodgkin lymphoma. The role of new treatments, such as CAR T cells, allows us to consider radiation therapy after systemic treatment of relapsed diseases with low volume recurrence, which can be considered oligorecur...
Source: Cancer Radiotherapie - December 24, 2023 Category: Cancer & Oncology Authors: L Ollivier K Debbi N-H To A Cailleteau S Supiot A Mervoyer V Guimas Y Belkac émi Source Type: research
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations
CONCLUSIONS: Given the effectiveness of systemic treatments in hematologic malignancies, the oligometastasis stage is of little importance. A curative intent after local radiation therapy, even advanced stage, is possible, both with residual disease for advanced Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or solitary plasmocytoma, and even without evidence of disease after chemotherapy for Hodgkin or non-Hodgkin lymphoma. The role of new treatments, such as CAR T cells, allows us to consider radiation therapy after systemic treatment of relapsed diseases with low volume recurrence, which can be considered oligorecur...
Source: Cancer Radiotherapie - December 24, 2023 Category: Cancer & Oncology Authors: L Ollivier K Debbi N-H To A Cailleteau S Supiot A Mervoyer V Guimas Y Belkac émi Source Type: research
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations
CONCLUSIONS: Given the effectiveness of systemic treatments in hematologic malignancies, the oligometastasis stage is of little importance. A curative intent after local radiation therapy, even advanced stage, is possible, both with residual disease for advanced Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or solitary plasmocytoma, and even without evidence of disease after chemotherapy for Hodgkin or non-Hodgkin lymphoma. The role of new treatments, such as CAR T cells, allows us to consider radiation therapy after systemic treatment of relapsed diseases with low volume recurrence, which can be considered oligorecur...
Source: Cancer Radiotherapie - December 24, 2023 Category: Cancer & Oncology Authors: L Ollivier K Debbi N-H To A Cailleteau S Supiot A Mervoyer V Guimas Y Belkac émi Source Type: research
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations
CONCLUSIONS: Given the effectiveness of systemic treatments in hematologic malignancies, the oligometastasis stage is of little importance. A curative intent after local radiation therapy, even advanced stage, is possible, both with residual disease for advanced Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or solitary plasmocytoma, and even without evidence of disease after chemotherapy for Hodgkin or non-Hodgkin lymphoma. The role of new treatments, such as CAR T cells, allows us to consider radiation therapy after systemic treatment of relapsed diseases with low volume recurrence, which can be considered oligorecur...
Source: Cancer Radiotherapie - December 24, 2023 Category: Cancer & Oncology Authors: L Ollivier K Debbi N-H To A Cailleteau S Supiot A Mervoyer V Guimas Y Belkac émi Source Type: research
